Skip to main content
. 2019 Aug 6;293(1):15–29. doi: 10.1148/radiol.2019190173

Figure 6b:

Figure 6b:

Images in 75-year-old man with advanced non–small cell lung cancer with 90% programmed death-ligand 1 (PD-L1) expression at immunohistochemistry. (a) Baseline CT image shows lobulated mass in left upper lobe, consistent with primary lung cancer (arrow). (b) Follow-up CT image obtained after 2 months of nivolumab therapy shows marked tumor shrinkage, representing response to PD-1 blockade in this high PD-L1–expressing tumor (arrow).